STAT+: Drug company penalties for paying kickbacks to doctors failed to dent bottom lines, analysis finds

Drugmakers that were penalized for kickbacks paid only 2.2% of their U.S. revenue generated by selling drugs that were the focus of the alleged violations during the past quarter century.